PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 23, 2026Discover Oncology0 citationsOpen Access

Clinical presentation and treatment of plasmablastic myeloma-a multicenter retrospective analysis

ZLZhenhui LvXGXiaoqing GuoJYJunjing Yin

Key Points

  • This research aims to characterize the clinical features and explore treatment options for plasmablastic myeloma.
  • Multicenter retrospective analysis of patient data
  • Assessment of clinical presentation and treatment responses
  • Exploration of potential therapies like CAR-T and allogeneic stem cell transplantation
  • Plasmablastic myeloma shows rapid progression and high tumor burden
  • Observed poor prognosis with prevalent high-risk genetic abnormalities
  • Potential new treatment avenues include CAR-T therapy and allogeneic transplantation.

Abstract

PBM has a low incidence, rapid cell proliferation, high tumor burden, multiple high-risk genetic abnormalities, rapid progression and poor prognosis. PBM frequently affects extramedullary sites. There is currently no standard treatment for PBM. CAR-T therapy may be a new option. Allogeneic hematopoietic stem cell transplantation is also the direction of exploration.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lv et al. (2026) studied this question.

synapsesocial.com/papers/69e9b62685696592c86eae41https://doi.org/10.1007/s12672-026-05071-4
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rare case of plasmablastic myeloma diagnosed on lung biopsy2021 · 8 citations
  2. 2Multiple myeloma: significance of plasmablastic subtype in morphological classification1985 · 261 citations
  3. 3The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patientsple Myeloma Patients2017 · 18 citations
  4. 4THT CLINICAL AND LAB0RATORY FEATURES OF 432 PATIENTS WITH MULTIPLE MYELOMA2004 · 2 citations
  5. 5NCCN Guidelines® Insights: Multiple Myeloma, Version 3.20222022 · 216 citations